IDH1 and glioblastoma: Our experiments demonstrated high levels of IDH1, PDPN, Hsp70, and Hsp90 in sEVs and lEVs, suggesting that these proteins sustain the GBM growth and invasiveness and could be exploited as new biomarkers of the disease.